Junevity Funding & Investors
Junevity is a biotech rewinding complex metabolic disease. Based on 6 years of breakthrough research at UCSF, Junevity's REWIND platform identifies high-level regulators of metabolic disease with known pharmacological pathways. Junevity is advancing multiple therapeutic programs towards a new era of medicines.
junevity.comTotal Amount Raised: $10,000,000
Junevity Funding Rounds
Seed
$10,000,000
Seed Investors
Godfrey CapitalGoldcrest Capital
Funding info provided by Diffbot.